Healthcare News

October 12, 2023 – Company announcement no. 9 Strong performance for the quarter despite a challenging environment  Statement by CEO Mauricio Graber: “Supported by a strong Q4 performance, Chr....

VANCOUVER, British Columbia, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE: 0NFA), a biotechnology...

Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial...

PERSBERICHT 12 oktober 2023, 7:00 CEST Biocartis kondigt uitbreiding aan van de samenwerking met APIS Assay Technologies en zal de APIS ESR1 Mutations Kit commercialiseren Mechelen, België, 12...

PRESS RELEASE 12 October 2023, 7:00 CEST Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit Mechelen, Belgium, 12 October...

10-year efficacy data highlight OCREVUS’ impact on preventing disability progression and maintaining mobility in both relapsing and progressive forms of multiple sclerosis (MS)10-year safety data from...

No confirmed patient deaths occurred in cohort 1 between the 3-year and 4-year follow-up. Oslo, October 12, 2023: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage...

Gereglementeerde informatie - voorwetenschapNazareth (België)/Rotterdam (Nederland), 12 oktober 2023 – 7u CET Aanhoudend sterke prestaties derde kwartaal met 11% omzetgroei naar €191 miljoen ...

Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 October 2023 – 7:00 AM CET Continued strong third quarter performance with 11% topline growth to €191...

CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases,...